• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国农业部关于兽用钩端螺旋体疫苗效力测试的监管指南与实践。

USDA regulatory guidelines and practices for veterinary Leptospira vaccine potency testing.

作者信息

Srinivas G B, Walker A, Rippke B

机构信息

Center for Veterinary Biologics, Animal and Plant Health Inspection Service, United States Department of Agriculture, P.O. Box 844, Ames, IA 50010, USA.

出版信息

Biologicals. 2013 Sep;41(5):298-302. doi: 10.1016/j.biologicals.2013.06.005. Epub 2013 Jul 6.

DOI:10.1016/j.biologicals.2013.06.005
PMID:23838570
Abstract

Batch-release potency testing of leptospiral vaccines licensed by the United States Department of Agriculture (USDA) historically was conducted through animal vaccination-challenge models. The hamster vaccination-challenge assay was Codified in 1974 for bacterins containing Leptospira pomona, Leptospira icterohaemorrhagiae, and Leptospira canicola, and in 1975 for bacterins containing Leptospira grippotyphosa. In brief, 10 hamsters are vaccinated with a specified dilution of bacterin. After a holding period, the vaccinated hamsters, as well as nonvaccinated controls, are challenged with virulent Leptospira and observed for mortality. Eighty percent of vaccinated hamsters must survive in the face of a valid challenge. The high cost of the Codified tests, in terms of monetary expense and animal welfare, prompted the Center for Veterinary Biologics (CVB) to develop ELISA alternatives for them. Potency tests for other serogroups, such as Leptospira hardjo-bovis, that do not have Codified requirements for potency testing continue to be examined on a case-by-case basis.

摘要

美国农业部(USDA)许可的钩端螺旋体疫苗的批签发效价测试历来是通过动物接种-攻毒模型进行的。仓鼠接种-攻毒试验于1974年编入法典,用于含波摩那钩端螺旋体、出血性黄疸钩端螺旋体和犬型钩端螺旋体的菌苗,1975年编入法典用于含七日热钩端螺旋体的菌苗。简而言之,用特定稀释度的菌苗对10只仓鼠进行接种。经过一段饲养期后,对接种的仓鼠以及未接种的对照仓鼠用强毒钩端螺旋体进行攻毒,并观察死亡率。在有效的攻毒情况下,80%接种的仓鼠必须存活。从金钱成本和动物福利方面来看,编入法典的试验成本高昂,促使兽用生物制品中心(CVB)为其开发酶联免疫吸附测定(ELISA)替代方法。对于其他血清群,如没有效价测试编入法典要求的牛硬钩端螺旋体,效价测试仍在逐案审查中。

相似文献

1
USDA regulatory guidelines and practices for veterinary Leptospira vaccine potency testing.美国农业部关于兽用钩端螺旋体疫苗效力测试的监管指南与实践。
Biologicals. 2013 Sep;41(5):298-302. doi: 10.1016/j.biologicals.2013.06.005. Epub 2013 Jul 6.
2
Development of in vitro assays for measuring the relative potency of leptospiral bacterins containing serogroups canicola, grippotyphosa, icterohaemorrhagiae, and pomona.用于测定包含犬型、爪哇型、出血性黄疸型和波摩那型血清群的钩端螺旋体菌苗相对效力的体外检测方法的开发。
Biologicals. 2013 Sep;41(5):308-14. doi: 10.1016/j.biologicals.2013.06.007. Epub 2013 Jul 16.
3
Opportunities and strategies to further reduce animal use for Leptospira vaccine potency testing.进一步减少用于钩端螺旋体疫苗效力测试的动物使用量的机会和策略。
Biologicals. 2013 Sep;41(5):332-7. doi: 10.1016/j.biologicals.2013.06.006. Epub 2013 Jul 24.
4
Re-evaluating the LD50 requirements in the codified potency testing of veterinary vaccines containing Leptospira (L.) serogroup Icterohaemorrhagiae and L. serogroup Canicola in the United States.重新评估美国对含有出血性黄疸型钩端螺旋体血清群和犬型钩端螺旋体血清群的兽用疫苗进行法定效力测试时的半数致死剂量要求。
Biologicals. 2018 Nov;56:13-18. doi: 10.1016/j.biologicals.2018.08.003. Epub 2018 Aug 17.
5
International regulatory requirements for Leptospira vaccine potency testing. Roundtable: current requirements and opportunity for harmonization.钩端螺旋体疫苗效力测试的国际监管要求。圆桌会议:当前要求及协调机会。
Biologicals. 2013 Sep;41(5):305-7. doi: 10.1016/j.biologicals.2013.06.008. Epub 2013 Jul 23.
6
Expansion of the in vitro assay for Leptospira potency testing to other serovars: case study with Leptospira Hardjo.将钩端螺旋体效力测试的体外试验扩展至其他血清型:以哈焦钩端螺旋体为例的案例研究
Biologicals. 2013 Sep;41(5):323-4. doi: 10.1016/j.biologicals.2013.06.003. Epub 2013 Jul 6.
7
European regulatory framework and practices for veterinary Leptospira vaccine potency testing.欧洲兽用钩端螺旋体疫苗效力测试的监管框架与实践
Biologicals. 2013 Sep;41(5):303-4. doi: 10.1016/j.biologicals.2013.06.014. Epub 2013 Jul 22.
8
Successful development and validation of an in vitro replacement assay for Leptospira vaccine potency tests.钩端螺旋体疫苗效力测试体外替代试验的成功开发与验证。
Dev Biol (Basel). 2012;134:101-6.
9
Report on the international workshop on alternative methods for Leptospira vaccine potency testing: state of the science and the way forward.钩端螺旋体疫苗效力检测替代方法国际研讨会报告:科学现状与未来发展方向
Biologicals. 2013 Sep;41(5):279-94. doi: 10.1016/j.biologicals.2013.06.013. Epub 2013 Jul 23.
10
Efficacy of vaccination of cattle with the Leptospira interrogans serovar hardjo type hardjoprajitno component of a pentavalent Leptospira bacterin against experimental challenge with Leptospira borgpetersenii serovar hardjo type hardjo-bovis.用五价钩端螺旋体菌苗中问号钩端螺旋体哈焦型哈焦普拉吉诺成分对牛进行疫苗接种,以抵抗波摩那钩端螺旋体哈焦型哈焦-波维斯血清型的实验性攻击的效果。
Am J Vet Res. 2012 May;73(5):735-40. doi: 10.2460/ajvr.73.5.735.

引用本文的文献

1
Peromyscus spp. Deer Mice as Rodent Model of Acute Leptospirosis.白足鼠属。鹿鼠作为急性钩端螺旋体病的啮齿动物模型。
Emerg Infect Dis. 2025 Jul;31(7):1365-1376. doi: 10.3201/eid3107.241579.
2
Challenges for the development of a universal vaccine against leptospirosis revealed by the evaluation of 22 vaccine candidates.通过对 22 种候选疫苗的评估,揭示了开发通用钩端螺旋体病疫苗所面临的挑战。
Front Cell Infect Microbiol. 2022 Oct 7;12:940966. doi: 10.3389/fcimb.2022.940966. eCollection 2022.
3
Transcriptome and proteome analysis of innate immune responses to inactivated Leptospira and bivalent Leptospira vaccines in canine 030-D cells.
犬 030-D 细胞对灭活钩端螺旋体和双价钩端螺旋体疫苗固有免疫反应的转录组和蛋白质组分析。
Sci Rep. 2022 Aug 4;12(1):13418. doi: 10.1038/s41598-022-16457-z.
4
Replacement of in vivo leptospirosis vaccine potency testing in the United States.在美国替代活体钩端螺旋体病疫苗效力检测。
Biologicals. 2022 Jul;78:36-44. doi: 10.1016/j.biologicals.2022.05.001. Epub 2022 Jun 24.
5
Investigating the Immunological and Biological Equilibrium of Reservoir Hosts and Pathogenic : Balancing the Solution to an Acute Problem?研究储存宿主与病原体之间的免疫和生物平衡:平衡急性问题的解决方案?
Front Microbiol. 2020 Aug 14;11:2005. doi: 10.3389/fmicb.2020.02005. eCollection 2020.
6
Human leptospirosis vaccines in China.中国的人型钩端螺旋体病疫苗。
Hum Vaccin Immunother. 2018 Apr 3;14(4):984-993. doi: 10.1080/21645515.2017.1405884. Epub 2017 Dec 19.
7
A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction?一种通用的钩端螺旋体病疫苗:我们是否正朝着正确的方向前进?
Front Immunol. 2017 Mar 9;8:256. doi: 10.3389/fimmu.2017.00256. eCollection 2017.
8
LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis.LigB亚基疫苗在钩端螺旋体病仓鼠模型中对攻击具有无菌免疫力。
PLoS Negl Trop Dis. 2017 Mar 16;11(3):e0005441. doi: 10.1371/journal.pntd.0005441. eCollection 2017 Mar.